Latest Breaking News On - Theriva biologics europe - Page 1 : comparemela.com

Theriva Biologics (NYSE:NYSE:TOVX) Q3 2022 Earnings Conference Call November 10, 2022 08:30 ET Company Participants Chris Calabrese - Investor Relations Steven Shallcross - Chief Executive.

Frank tufaroVince wacherTheriva biologics europeChris calabreseTheriva biologicsManel cascallSteven shallcrossJim molloyExchange commissionCompany participantsProduct developmentAlliance global partnersProduct development of theriva biologicsConference call novemberChief financialSynthetic biologics